
|Articles|August 10, 2011
Blood Pressure, Circulation Supplement to Enter Clinical Trial
Dietary supplements brand Nathans Natural announced that its Levodyn supplement will begin a Phase II clinical trial.
Advertisement
Dietary supplements brand Nathans Natural announced that its Levodyn supplement will begin a Phase II clinical trial to study its safety and efficacy in lowering blood pressure and improving blood circulation in mildly hypertensive subjects.
The company says that the trial will be a double-blind, randomized, placebo-controlled, parallel-group, multicenter study. It will be performed by contract research organization Vedic Lifesciences (Redwood Shores, CA).
Advertisement
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
New Report Calls for Combined Sodium-Potassium Strategy in Hypertension Management
2
Ross Introduces 250-Gallon Retention Mixers for High-Pressure Processing
3
RFI Ingredients Takes On Minority Investment From Astanor to Fund Global Expansion
4
Collagen Sourcing and Production Methods for Finished Product Manufacturers
5





